Double hits in schizophrenia

Abstract

The co-occurrence of a copy number variant (CNV) and a functional variant on the other allele may be a relevant genetic mechanism in schizophrenia. We hypothesized that the cumulative burden of such double hits-in particular those composed of a deletion and a coding single-nucleotide variation (SNV)-is increased in patients with schizophrenia. We combined CNV data with coding variants data in 795 patients with schizophrenia and 474 controls. To limit false CNV-detection, only CNVs called by two algorithms were included. CNV-affected genes were subsequently examined for coding SNVs, which we termed "CNV-SNVs." Correcting for total queried sequence, we assessed the CNV-SNV-burden and the combined predicted deleterious effect. We estimated P-values by permutation of the phenotype. We detected 105 CNV-SNVs; 67 in duplicated and 38 in deleted genic sequence. Although the difference in CNV-SNVs rates was not significant, the combined deleteriousness inferred by CNV-SNVs in deleted sequence was almost 4-fold higher in cases compared with controls (nominal P ¼ 0.009). This effect may be driven by a higher number of CNV-SNVs and/or by a higher degree of predicted deleteriousness of CNV-SNVs. No such effect was observed for duplications. We provide early evidence that deletions co-occurring with a functional variant may be relevant, albeit of modest impact, for the genetic etiology of schizophrenia. Large-scale consortium studies are required to validate our findings. Sequence-based analyses would provide the best resolution for detection of CNVs as well as coding variants genome-wide. † Research Group Authorship-see acknowledgement section for individual members.

Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk

“…Use of a schizophrenia PRS in clinical practice hinges on improved accuracy, especially in persons of non-European ancestry, and GWASs that include individuals from diverse populations are essential (49). In addition, inherited or de novo genetic factors such as copy number variants, methylation marks, and rare but highly penetrant polymorphisms not captured in this analysis of common variants could be added, and improved algorithms to generate genetic risk scores are in development (55)(56)(57)(58). With further improvements and given the relatively low cost and wide availability of genotyping, potential applications of the genetic risk scores to individualized psychosis risk screening warrant further investigation.…”

ARHGAP10, which encodes Rho GTPase-activating protein 10, is a novel gene for schizophrenia risk

“…In addition, to examine the role of ARHGAP10 in the pathogenesis of SCZ, we focused on a SCZ patient who was revealed to carry an exonic deletion of ARHGAP10 as well as a rare missense variant on the other ARHGAP10 allele. The co-occurrence of such variants in the same gene has been recently suggested to be an important genetic mechanism of SCZ 23 . To further examine this issue, we generated a compound heterozygous mutant mouse of the same genotype as the patient and compared the in vitro phenotypes with those of induced pluripotent stem cells (iPSCs) derived from the patient.…”

Chromatin remodeling dysfunction extends the etiological spectrum of schizophrenia: a case report

“…To our knowledge, the 16p13.3 duplication affects genes that have not been related to neurodevelopment. However, we cannot exclude a modulating role of this copy number variation on the phenotype, as has previously been described for double-hit carrier patients [24,25].…”